Cutting-edge technologies powering gene and cell therapies today and for many decades to come

Enabling

Technologies

ElevateBio has been built to establish and leverage our expertise across multiple, integrated next-generation enabling technologies, including gene editing, iPSCs, and cell, protein, and vector engineering. With our highly innovative, next-generation enabling technologies under one roof and numerous experts in each field, we possess the ability to discover, develop, and manufacture therapeutics across a broad spectrum of cutting-edge cell and gene therapy technologies.

Gene Editing

Highly innovative genome editing technology platform with RNA-guided nucleases, base editors, and PAM diversity

iPSCs

Setting a new standard with fully characterized, clinical-grade iPSC lines to accelerate the development of iPSC-derived immunotherapies and regenerative medicines

Cell, Protein, and Vector Engineering

Platforms that enable the construction and scaling of cell and gene therapies, with a focus on immunotherapies

We’re the partner of choice for the world’s most innovative academic researchers and entrepreneurs.

Building an alliance with Massachusetts General Hospital

The strategic partnership gives MGH preferred access to ElevateBio’s BaseCamp research, process development, and manufacturing facility. ElevateBio will support a variety of MGH’s cell and gene therapy research programs. Our organizations will work together to identify cell and gene technologies and create therapeutics companies.

learn more

Translating research into life-changing treatments with Boston Children’s Hospital

Collaborating with Boston Children’s Hospital to advance cell and gene therapy programs, ElevateBio is helping BHC researchers move their therapies through development more efficiently with access to our cutting-edge viral vector manufacturing facilities. This alliance will help accelerate the development of multiple cell and gene therapy platforms.

Learn more